Outsourcing STREAM

  1. Multi-Site Capabilities For Your Phase I-II Trials 5/1/2026

    Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired patient populations.

  2. Outsourcing Clinical Trial Disclosure Management 6/3/2020

    Deciding to outsource clinical trial disclosure management is a sponsor’s first step. Deciding what processes to outsource is the next step. Two study sponsors discuss with TrialScope what they outsource and why. Watch the short video.

  3. Proactive Drug Development: Explained 1/30/2023

    Watch this short video to learn about Proactive Drug Development with Altasciences.

  4. How To Take Advantage Of Early Access Programs For The EU 6/12/2024

    Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.

  5. Streamlining Patient Access To Cell And Gene Therapies 12/21/2023

    Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.

  6. Imagine… Easier, Proactive Drug Development 2/14/2023

    Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.

  7. Mitigating Risk And Complexity In Cell & Gene Therapy Trials With IRT 8/19/2025

    CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.

  8. Altasciences Has You Covered From Coast To Coast 1/30/2023

    With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

  9. How Sponsors Turn Disclosure As A Service Into A Strategic Advantage 5/18/2020

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.

  10. We Are Altasciences: Proactive Drug Development 1/30/2023

    When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.